Clinical Trial Update: Evaluate the Clinical Usefulness of [F-18]Florastamin PET/CT Imaging Diagnosis Compared to MRI Diagnosis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the clinical usefulness of [F-18]Florastamin PET/CT imaging for diagnosing high-risk prostate cancer and comparing it with MRI…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• [F-18]Florastamin

Snippet

Sponsor: FutureChem | Conditions: High Risk Prostate Carcinoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING